PureTech Health plc (LON:PRTC)
London · Delayed Price · Currency is GBP · Price in GBX 115.00
+0.80 (0.70%)
At close: Mar 25, 2026
PureTech Health Market Cap
PureTech Health has a market cap or net worth of 279.53 million as of March 25, 2026. Its market cap has decreased by -8.36% in one year.
Market Cap
279.53M
Enterprise Value
152.04M
Revenue
4.66M
Ranking
n/a
PE Ratio
7.82
Stock Price
115.00
Market Cap Chart
Since June 19, 2015, PureTech Health's market cap has decreased from 404.50M to 279.53M, a decrease of -30.90%. That is a compound annual growth rate of -3.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 277.58M | -8.12% |
| Dec 31, 2025 | 302.11M | -15.99% |
| Dec 31, 2024 | 359.61M | -31.88% |
| Dec 29, 2023 | 527.94M | -28.89% |
| Dec 30, 2022 | 742.38M | -11.66% |
| Dec 31, 2021 | 840.37M | -26.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genus | 1.70B |
| Oxford Nanopore Technologies | 1.12B |
| Oxford Biomedica | 727.66M |
| Avacta Group | 290.87M |
| Scancell Holdings | 119.34M |
| 4basebio | 80.48M |
| Bioventix | 73.67M |
| Hemogenyx Pharmaceuticals | 62.83M |